Immutep Competitors

Pink Sheets . USA . 
Stock . Immutep Limited
PRRUF Stock  USD 0.24  0.00  0.00%   
Immutep Limited competes with HUMANA, Barloworld, Morningstar Unconstrained, High Yield, and Thrivent High; as well as few others. The company classifies itself under Healthcare sector and is part of Biotechnology industry. Analyzing Immutep competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Immutep to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Immutep Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Immutep competition on your existing holdings.
  
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Immutep's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.010.241.46
Details
Intrinsic
Valuation
LowRealHigh
0.010.201.42
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Immutep. Your research has to be compared to or analyzed against Immutep's peers to derive any actionable benefits. When done correctly, Immutep's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Immutep Limited.

Immutep Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Immutep and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Immutep and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Immutep Limited does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
ABHYX
+ 0.82
MSTSX
VIASP
+ 0.78
MSTSX
BRRAY
+ 0.76
MYMX
LBHIX
+ 0.72
MSTSX
MSTSX
+ 0.71
AQUI
LBHIX
+ 0.7
ABHYX
  
High negative correlations   
MSTSX
- 0.81
BRRAY
VIASP
- 0.79
BRRAY
MSTSX
- 0.73
MYMX
ABHYX
- 0.7
BRRAY
BRRAY
- 0.68
AQUI
ABHYX
- 0.56
MYMX

Risk-Adjusted Indicators

There is a big difference between Immutep Pink Sheet performing well and Immutep Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Immutep's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
MYMX  3.03 (0.20) 0.00  0.02  0.00 
 0.00 
 0.00 
 0.00 
 196.15 
444859BR2  0.78  0.08  0.03  0.24  1.03 
(0.92)
 1.12 
(1.04)
 10.31 
AQUI  1.32  0.62  0.00  1.04  0.00 
 0.00 
 0.00 
 0.00 
 25.00 
BRRAY  0.63 (0.17) 0.00  0.33  0.00 
 0.00 
 0.00 
 0.00 
 18.45 
MSTSX  0.46 (0.01)(0.03) 0.07  0.60 
(0.51)
 1.03 
(1.06)
 3.20 
ABHYX  0.16  0.01 (0.22) 2.44  0.19 
(0.22)
 0.45 
(0.34)
 1.61 
LBHIX  0.19 (0.02)(0.24)(0.01) 0.21 
(0.30)
 0.49 
(0.48)
 1.21 
SCAXF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
VIASP  1.40  0.18  0.09  0.24  1.87 
(1.52)
 3.60 
(2.72)
 13.41 

Immutep Competitive Analysis

The better you understand Immutep competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Immutep's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Immutep's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
PRRUF MYMX 444859BR2 AQUI BRRAY MSTSX ABHYX LBHIX SCAXF VIASP
 0.00 
 0.24 
Immutep
 0.00 
 0.01 
Mymetics
 0.00 
 84.12 
HUMANA
 0.00 
 0.01 
Aquagold
 0.00 
 3.54 
Barloworld
 0.85 
 10.68 
Morningstar
 0.11 
 8.71 
High
 0.49 
 4.12 
Thrivent
 0.00 
 0.01 
Sparta
 1.49 
 19.79 
Via
Market Volatility
(90 Days Market Risk)
Abnormally volatile
Out of control
Very steady
Out of control
Out of control
Very steady
Very steady
Very steady
Very steady
Very steady
Market Performance
(90 Days Performance)
Insignificant
Very Weak
Modest
OK
Very Weak
OK
Modest
Very Weak
Very Weak
OK
Odds of Financial Distress
(Probability Of Bankruptcy)
Low
Quite High
Below Average
Below Average
Low
Low
Low
Low
Low
Average
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Over Valued
Under Valued
Fairly Valued
Fairly Valued
Fairly Valued
Over Valued
Fairly Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Strong Sell
Strong Hold
Strong Sell
Not Rated
Strong Hold
Sell
Hold
Strong Sell
Strong Hold
Current Ratio
14.16
0.01
N/A
N/A
1.49
N/A
N/A
N/A
0.62
3.49
Net Asset
148.52 M
7.63 M
N/A
3.19 K
54.41 B
116.1 M
672.37 M
674.44 M
3.06 M
355.28 M
EBITDA
(43.69 M)
(1.96 M)
N/A
(727.69 K)
2.77 B
N/A
N/A
N/A
(21.53 K)
33.09 M
Operating Margin
-7.18
-1.76
N/A
N/A
0.1
N/A
N/A
N/A
-0.15
-0.14
Five Year Return
N/A
N/A
N/A
N/A
3.98
6.96
1.63
2.57
N/A
8.97
One Year Return
N/A
N/A
N/A
N/A
N/A
10.06
4.55
7.54
N/A
N/A
Beta
1.95
0.24
N/A
7.05
0.63
N/A
N/A
N/A
1.75
1.16
Number Of Employees
17
9
N/A
7
36
1
1
1
8
169
Three Year Return
N/A
N/A
N/A
N/A
N/A
3.79
-1.66
1.2
N/A
N/A
Cash Flow From Operations
(30.23 M)
(1.7 M)
N/A
(218.19 K)
1.89 B
N/A
N/A
N/A
210.37 K
12.7 M
Total Debt
2.11 M
162 K
N/A
N/A
8.64 B
N/A
N/A
N/A
125 K
135 M
Bond Positions Weight
N/A
N/A
N/A
N/A
N/A
22.72
2.0
92.23
N/A
N/A
Holdings Turnover
N/A
N/A
N/A
N/A
N/A
269.0
N/A
N/A
N/A
N/A
Return On Asset
-0.23
-0.14
N/A
-5.5
0.047
N/A
N/A
N/A
-0.21
-0.11
Current Liabilities
1000 K
51.24 M
N/A
794 K
13.9 B
N/A
N/A
N/A
N/A
N/A
Debt To Equity
0.018
N/A
N/A
N/A
0.68
N/A
N/A
N/A
101.0
0.69
Short Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
0.7
Shares Owned By Institutions
24.04
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Market Capitalization
171.77 M
5.47 M
N/A
96.58 K
955.54 M
50.36 M
N/A
N/A
7.72 M
N/A
Price To Earning
-2.5
-2.4
N/A
-0.22
9.18
N/A
N/A
35.48
19.55
26.83
Price To Sales
33.12
12.17
N/A
N/A
0.0285
N/A
N/A
1.23
0.63
N/A
Net Income
(32.21 M)
(4.73 M)
N/A
(627.79 K)
2.04 B
N/A
N/A
N/A
(609.44 K)
5.2 M
Shares Owned By Insiders
4.61
54.9
N/A
N/A
N/A
N/A
N/A
N/A
9.51
N/A
Revenue
247.66 K
3 K
N/A
N/A
39.38 B
N/A
N/A
N/A
5.19 M
393.49 M
Year To Date Return
N/A
N/A
N/A
N/A
N/A
0.77
0.51
0.0155
N/A
N/A
Working Capital
21 M
(49.86 M)
N/A
(794 K)
11.95 B
N/A
N/A
N/A
N/A
N/A
Profit Margin
N/A
N/A
N/A
N/A
0.0519
N/A
N/A
N/A
-0.1
0.0094
Current Valuation
142.99 M
83.16 M
N/A
912.76 K
1.11 B
N/A
N/A
N/A
5.73 M
535.95 M
Price To Book
2.81
N/A
N/A
N/A
0.99
N/A
N/A
1.58
34.42
N/A
Retained Earnings
(222 M)
(81.98 M)
N/A
(4.18 M)
13.37 B
N/A
N/A
N/A
N/A
N/A
Current Asset
22 M
1.38 M
N/A
N/A
25.84 B
N/A
N/A
N/A
N/A
N/A
Cash Position Weight
N/A
N/A
N/A
N/A
N/A
14.28
0.1
6.56
N/A
N/A
Equity Positions Weight
N/A
N/A
N/A
N/A
N/A
61.63
N/A
0.07
N/A
N/A
Shares Outstanding
879.09 M
303.76 M
N/A
965.83 K
185.7 M
N/A
N/A
N/A
233.95 M
N/A
Annual Yield
N/A
N/A
N/A
N/A
0.0543
0.0223
0.0041
0.0582
N/A
0.0972
Return On Equity
-0.38
N/A
N/A
N/A
0.0588
N/A
N/A
N/A
N/A
0.017
Z Score
47.2
-1.4
N/A
N/A
N/A
N/A
N/A
N/A
37.6
1.0
Book Value Per Share
0.11
-0.21
N/A
-1.18
99.76
N/A
N/A
N/A
-0.002
3.66
Number Of Shares Shorted
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
4.29 K
Minimum Initial Investment
N/A
N/A
N/A
N/A
N/A
N/A
N/A
2 K
N/A
N/A
Total Asset
148.52 M
7.63 M
N/A
3.19 K
54.41 B
215.11 M
243.16 M
347.66 M
3.06 M
355.28 M
Target Price
N/A
N/A
N/A
N/A
7.68
N/A
N/A
N/A
N/A
N/A
Last Dividend Paid
N/A
N/A
N/A
N/A
4.6
N/A
0.03
0.02
N/A
0.73
Earnings Per Share
-0.024
-0.016
N/A
-0.63
0.35
N/A
N/A
N/A
-0.003
1.17
Ten Year Return
N/A
N/A
N/A
N/A
N/A
N/A
4.84
6.0
N/A
N/A
Cash And Equivalents
80 M
350 K
N/A
1.15 K
5.11 B
N/A
N/A
N/A
909.32 K
51.31 M
Cash Per Share
0.09
N/A
N/A
N/A
25.52
N/A
N/A
N/A
N/A
3.23
Gross Profit
(26.63 M)
(545 K)
N/A
(143.88 K)
5.12 B
N/A
N/A
N/A
3.68 M
74.67 M
Day Typical Price
0.24
0.01
84.12
0.006
3.54
10.68
8.71
4.12
0.0121
19.63
Accumulation Distribution
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
0.0243
Market Facilitation Index
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
0.48
Daily Balance Of Power
0.0
0.0
0.0
0.0
0.0
9.2 T
9.2 T
9.2 T
0.0
0.6042
Period Momentum Indicator
N/A
N/A
N/A
N/A
N/A
0.09
0.01
0.02
N/A
0.29
Rate Of Daily Change
1.0
1.0
1.0
1.0
1.0
1.01
1.0
1.0
1.0
1.01
Day Median Price
0.24
0.01
84.12
0.006
3.54
10.68
8.71
4.12
0.0121
19.55
Price Action Indicator
N/A
N/A
N/A
N/A
N/A
0.045
0.005
0.01
N/A
0.38
Coefficient Of Variation
1665.64
29527.27
1237.18
573.64
(940.98)
848.08
1408.39
3349.72
N/A
721.85
Mean Deviation
0.2613
3.03
0.775
1.32
0.6346
0.4634
0.1628
0.186
N/A
1.4
Jensen Alpha
0.037
(0.20)
0.0804
0.6166
(0.17)
(0.01)
0.0075
(0.02)
N/A
0.1761
Total Risk Alpha
(0.10)
(2.31)
(0.10)
0.1367
(0.51)
(0.02)
(0.03)
(0.04)
N/A
(0.01)
Sortino Ratio
N/A
N/A
0.0308
N/A
N/A
(0.03)
(0.22)
(0.24)
N/A
0.0882
Downside Variance
N/A
N/A
1.64
N/A
N/A
0.5671
0.1289
0.1302
N/A
4.51
Standard Deviation
1.19
17.21
1.67
3.91
2.06
0.6331
0.2508
0.258
N/A
2.04
Kurtosis
46.54
32.55
13.29
32.12
22.82
1.6
3.54
0.1983
N/A
2.87
Potential Upside
N/A
N/A
1.12
N/A
N/A
1.03
0.4545
0.4854
N/A
3.6
Treynor Ratio
0.2157
0.0167
0.2399
1.04
0.3307
0.0745
2.44
(0.01)
N/A
0.2411
Maximum Drawdown
12.7
196.15
10.31
25.0
18.45
3.2
1.61
1.21
N/A
13.41
Variance
1.4
296.08
2.78
15.3
4.23
0.4008
0.0629
0.0665
N/A
4.16
Market Risk Adjusted Performance
0.2257
0.0267
0.2499
1.05
0.3407
0.0845
2.45
3.0E-4
N/A
0.2511
Risk Adjusted Performance
0.0422
0.0117
0.0567
0.1171
(0.06)
0.0737
0.0294
0.0044
N/A
0.0933
Skewness
5.47
0.3352
1.93
5.72
(3.59)
(0.75)
(0.43)
(0.29)
N/A
(0.26)
Semi Deviation
N/A
N/A
1.03
N/A
N/A
0.598
0.1898
0.206
N/A
1.87
Information Ratio
(0.02)
(0)
0.0237
0.15
(0.15)
(0.03)
(0.31)
(0.34)
N/A
0.0918
Value At Risk
N/A
N/A
(1.04)
N/A
N/A
(1.06)
(0.34)
(0.48)
N/A
(2.72)
Expected Short fall
N/A
N/A
(0.92)
N/A
N/A
(0.51)
(0.22)
(0.30)
N/A
(1.52)
Downside Deviation
N/A
N/A
1.28
N/A
N/A
0.753
0.3591
0.3609
N/A
2.12
Semi Variance
N/A
N/A
1.07
N/A
N/A
0.3576
0.036
0.0424
N/A
3.49

Immutep Competition Performance Charts

Five steps to successful analysis of Immutep Competition

Immutep's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Immutep Limited in relation to its competition. Immutep's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Immutep in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Immutep's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Immutep Limited, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Immutep position

In addition to having Immutep in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Office Supplies Thematic Idea Now

Office Supplies
Office Supplies Theme
Companies producing and selling office supplies, and accessories. The Office Supplies theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Office Supplies Theme or any other thematic opportunities.
View All  Next Launch
Check out Immutep Correlation with its peers.
You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Complementary Tools for Immutep Pink Sheet analysis

When running Immutep's price analysis, check to measure Immutep's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immutep is operating at the current time. Most of Immutep's value examination focuses on studying past and present price action to predict the probability of Immutep's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immutep's price. Additionally, you may evaluate how the addition of Immutep to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Altman
Z Score
Details
Intrinsic
Valuation
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Technical
Analysis
Details
Please note, there is a significant difference between Immutep's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immutep is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immutep's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY